XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Note 12 - Grants and Collaboration Revenue
6 Months Ended
Jun. 30, 2020
Notes to Financial Statements  
Government Grants and Contracts [Text Block]
12.
        Grants and Collaboration Revenue
 
We receive payments from government entities under our grants from the National Institute of Allergy and Infectious Diseases (NIAID) and from the U.S. Department of Defense in support of our vaccine research and development efforts. We record revenue associated with government grants as the reimbursable costs are incurred. During the
three
-month and
six
-month periods ended
June 30, 2020,
we recorded
$301,493
and
$955,514,
respectively, of revenues associated with these grants and contracts, as compared to
$184,938
and
$539,257,
respectively, for the comparable periods of
2019.
As of
June 30, 2020,
there is an aggregate of
$650,051
in approved grant funds available for use through
September 2021.
 
During the
three
-month and
six
-month periods ended
June 30, 2020,
we recorded
$139,109
and
$201,065,
respectively, of revenues associated with research collaboration agreements with
third
parties, as compared to
$25,003
and
$34,916,
respectively, for the comparable periods of
2019.